INDIVIOR PLC (INDV) Stock Price, Quote, News and Overview
NASDAQ:INDV - Nasdaq - GB00BN4HT335 - Common Stock - Currency: USD
INDV Quote, Performance and Key Statistics
20.2
+2.8 (+16.09%)
The current stock price of INDV is 20.2 USD. In the past month the price increased by 31.17%. In the past year, price increased by 48.86%.
INDV Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 53.78 | 701.39B | ||
| JNJ | JOHNSON & JOHNSON | 16.47 | 396.38B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 16.46 | 226.61B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 12.85 | 220.18B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 13.08 | 209.15B | ||
| MRK | MERCK & CO. INC. | 10.15 | 196.16B | ||
| PFE | PFIZER INC | 7.26 | 132.41B | ||
| SNY | SANOFI-ADR | 11.67 | 111.31B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.44 | 88.14B | ||
| GSK | GSK PLC-SPON ADR | 8.33 | 74.96B | ||
| ZTS | ZOETIS INC | 24.22 | 64.91B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 47.31 | 43.33B |
Related stock screener links
About INDV
Company Profile
Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. The company is headquartered in Chesterfield Virginia, Virginia and currently employs 1,030 full-time employees. The company went IPO on 2014-12-23. The firm provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The firm sells its products in the United States and in other selected areas of the world.
Company Info
INDIVIOR PLC
10710 Midlothian Turnpike, Suite 125, North Chesterfield
Chesterfield Virginia VIRGINIA US
Employees: 1041
Phone: 8043791090
INDIVIOR PLC / INDV FAQ
What is the stock price of INDIVIOR PLC today?
The current stock price of INDV is 20.2 USD. The price increased by 16.09% in the last trading session.
What is the ticker symbol for INDIVIOR PLC stock?
The exchange symbol of INDIVIOR PLC is INDV and it is listed on the Nasdaq exchange.
On which exchange is INDV stock listed?
INDV stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for INDIVIOR PLC stock?
8 analysts have analysed INDV and the average price target is 14.88 USD. This implies a price decrease of -26.34% is expected in the next year compared to the current price of 20.2. Check the INDIVIOR PLC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is INDIVIOR PLC worth?
INDIVIOR PLC (INDV) has a market capitalization of 2.52B USD. This makes INDV a Mid Cap stock.
How many employees does INDIVIOR PLC have?
INDIVIOR PLC (INDV) currently has 1041 employees.
What are the support and resistance levels for INDIVIOR PLC (INDV) stock?
INDIVIOR PLC (INDV) has a support level at 16.28. Check the full technical report for a detailed analysis of INDV support and resistance levels.
Is INDIVIOR PLC (INDV) expected to grow?
The Revenue of INDIVIOR PLC (INDV) is expected to grow by 3.53% in the next year. Check the estimates tab for more information on the INDV EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy INDIVIOR PLC (INDV) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of INDV, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of INDV, evaluating the profitability, health, valuation and growth aspects
- INDIVIOR PLC (INDV) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- INDIVIOR PLC (INDV) Sales and EPS estimates to see what analysts future expectations are.
- INDIVIOR PLC (INDV) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- INDIVIOR PLC (INDV) Insider and Institutional Ownership to learn about the owners and their transactions.
- INDIVIOR PLC (INDV) Stock Chart to make your own analysis
- INDIVIOR PLC (INDV) Latest news and press-releases to stay up to date.
Does INDIVIOR PLC (INDV) stock pay dividends?
INDV does not pay a dividend.
When does INDIVIOR PLC (INDV) report earnings?
INDIVIOR PLC (INDV) will report earnings on 2025-10-23.
What is the Price/Earnings (PE) ratio of INDIVIOR PLC (INDV)?
The PE ratio for INDIVIOR PLC (INDV) is 11.54. This is based on the reported non-GAAP earnings per share of 1.75 and the current share price of 20.2 USD. Check the full fundamental report for a full analysis of the valuation metrics for INDV.
What is the Short Interest ratio of INDIVIOR PLC (INDV) stock?
The outstanding short interest for INDIVIOR PLC (INDV) is 7.23% of its float. Check the ownership tab for more information on the INDV short interest.
INDV Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to INDV. When comparing the yearly performance of all stocks, INDV is one of the better performing stocks in the market, outperforming 93.54% of all stocks.
INDV Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to INDV. INDV has only an average score on both its financial health and profitability.
INDV Financial Highlights
Over the last trailing twelve months INDV reported a non-GAAP Earnings per Share(EPS) of 1.75. The EPS decreased by -24.28% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
INDV Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to INDV. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 8.11% and a revenue growth 3.53% for INDV